QQ客服 官方微博 反馈留言

	Androgen-deprivation therapy with enzalutamide enhances prostate cancer metastasis via decreasing the EPHB6 suppressor expression
	Chen, Jiaqi; Li, Lei; Yang, Zhao; Luo, Jie; Yeh, Shuyuan; Chang, Chawnshang
刊名	CANCER LETTERS
	2017
卷号	408页码:155-163
关键词	Prostate cancer EPHB6 Androgen receptor
ISSN号	0304-3835
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2944846
专题	西安交通大学
推荐引用方式 GB/T 7714	Chen, Jiaqi,Li, Lei,Yang, Zhao,et al. Androgen-deprivation therapy with enzalutamide enhances prostate cancer metastasis via decreasing the EPHB6 suppressor expression[J]. CANCER LETTERS,2017,408:155-163.
APA	Chen, Jiaqi,Li, Lei,Yang, Zhao,Luo, Jie,Yeh, Shuyuan,&Chang, Chawnshang.(2017).Androgen-deprivation therapy with enzalutamide enhances prostate cancer metastasis via decreasing the EPHB6 suppressor expression.CANCER LETTERS,408,155-163.
MLA	Chen, Jiaqi,et al."Androgen-deprivation therapy with enzalutamide enhances prostate cancer metastasis via decreasing the EPHB6 suppressor expression".CANCER LETTERS 408(2017):155-163.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。